Living with or without cyclins and cyclin-dependent kinases

Genes and Development

Volumn 18, Issue 22, 2004, Pages 2699-2711

  Sherr, Charles J ^a   Roberts, James M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b USA   (United States)

Author keywords

Cdk2; Cdk4; Cdk6; Cell cycle; Cyclin D; Cyclin E

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; CYCLINE;

ANIMAL CELL; CELL CYCLE G1 PHASE; ENZYME REGULATION; FETUS DEVELOPMENT; GENE DISRUPTION; GERM LINE; MAMMAL CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

EID: 8644219655     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1256504     Document Type: Review

References (111)

1. Agami, R. and Bernards, R. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102: 55-66.
2. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, SJ., and Clarke, M.F. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 100: 3983-3988.
3. Baldin, V., Lukas, J., Marcote, M.J., Pagano, M., and Draetta, G. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes & Dev. 7: 812-821.
4. Berra, Y. 1998. The Yogi book: 'I really didn't say everything I said,' pp. 118-119. Workman Publishing, New York.
5. Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., and Kaldis, P. 2003. Cdk2 knockout mice are viable. Curr. Biol. 13: 1775-1785.
6. Bloom, J. and Pagano, M. 2003. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13: 41-47.
7. Brewer, J.W., Hendershot, L.M., Sherr, C.J., and Diehl, J.A. 1999. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc. Natl. Acad. Sci. 96: 8505-8510.
8. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583.
9. Ciemerych, M.A., Kenney, A.M., Sicinska, E., Kalaszczynska, I., Bronson, R.T., Rowitch, D.H., Gardner, H., and Sicinski, P. 2002. Development of mice expressing a single D-type cyclin. Genes & Dev. 16: 3277-3289.
10. Clurman, B.E., Sheaff, R.J., Thress, K., Groudine, M., and Roberts, J.M. 1996. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by CDK2 binding and cyclin phosphorylation. Genes & Dev. 10: 1979-1990.
11. Costanzo, M., Nishikawa, J.L., Tang, X., Millman, J.S., Schub, O., Breitkreuz, K., Dewar, D., Rupes, I., Andrews, B., and Tyers, M. 2004. CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell 117: 849-850.
12. Coverley, D., Laman, H., and Laskey, R.A. 2002. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat. Cell Biol. 4: 523-528.
13. Datar, S.A., Jacobs, H.W., de la Cruz, A.F., Lehner, C.F., and Edgar, B.A. 2000. The Drosophila cyclin D-cdk4 complex promotes cellular growth. EMBO J. 19: 4543-4554.
14. de Nooij, J.C., Letendre, M.A., and Hariharan, I.K. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87: 1237-1247.
15. Diehl, J.A., Cheng, M., Roussel, M.F., and Sherr, C.J. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes & Dev. 12: 192-229.
16. Donaldson, A.D. 2000. The yeast mitotic cyclin Clb2 cannot substitute for S phase cyclins in replication origin firing. EMBO Rep. 1: 507-512.
17. Dulic, V., Lees, E., and Reed, S.I. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961.
18. Duronio, R.J. and O'Farrell, P.H. 1995. Developmental control of the G1 to S transition in Drosophila: Cyclin E is a limiting downstream target of E2F. Genes & Dev. 9: 1456-1468.
19. Elledge, S.J. and Harper, J.W. 1998. The role of protein stability in the cell cycle and cancer. Biochem. Biophys. Acta 1377: M61-M70.
20. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kalo, J.-Y., and Livingston, D.M. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
21. Fang, F. and Newport, J.W. 1991. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66: 731-742.
22. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. 1995. Mice lacking cyclin Dl are small and show defects in eye and mammary gland development. Genes & Dev. 9: 2364-2372.
23. Fisher, D.L. and Nurse, P. 1996. A single fission yeast mitotic cyclin B-p34cdc2 kinase promotes both S-phase and mitosis in the absence of G1 cyclins. EMBO J. 15: 850-860.
24. Geng, Y., Whoriskey, W., Park, M.Y., Bronson, R.T., Medema, R.H., Li, T., Weinberg, R.A., and Sicinski, P. 1999. Rescue of cyclin Dl deficiency by knockin cyclin E. Cell 97: 767-777.
25. Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl. Acad. Sci. 98: 194-199.
26. Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J.E., Bhattacharya, S., Ridcout, W., Bronson, R.T., Gardner, H., and Sicinski, P. 2003. Cyclin E ablation in the mouse. Cell 114:431-443.
27. Guo, Y., Stacey, D.W., and Hitomi, M. 2002. Post-transcriptional regulation of cyclin D1 expression during G2 phase. Oncogene 21: 7545-7556.
28. Harbour, J.W. and Dean, D.C. 2000. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes & Dev. 14: 2393-2409.
29. Hua, X.H. and Newport, J. 1998. Identification of a preinitiation step in DNA replication that is independent of origin recognition complex and cdco, but dependent on cdk2. J. Cell Biol. 140:271-281.
30. Huard, J.M.T., Forster, C.C., Carter, M.L., Sicinski, P., and Ross, M.E. 1999. Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development 126: 1927-1935.
31. Min mice. Mol. Cell. Biol. 24: 7598-7611.
32. Jacobson, M.D., Gray, S., Yuste-Rojas, M., and Cross, F.R. 2000. Testing cyclin specificity in the exit from mitosis. Mol. Cell. Biol. 20: 4483-4493.
33. Jiang, W., Kahn, S.M., Zhou, P., Zhang, Y.-J., Cacace, A.M., Infante, A.S., Doi, S., Santella, R.M., and Weinstein, I.B. 1993. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene 8: 3447-3457.
34. Knoblich, J.A., Sauer, K., Jones, L., Richardson, H., Saint, R., and Lehner, C.F. 1994. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the airest of cell proliferation. Cell 77: 107-120.
35. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Morgan, D.O., Franza, B.R., and Roberts, J.M. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694.
36. Kozar, K., Ciemerych, M.A., Rebel, V.I., Shigematsu, H., Zagozdon, A., Sicinska, E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R.T., et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477-491.
37. Krude, T., Jackman, M., Pines, J., and Laskey, R.A. 1997. Cyclin/ cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88: 109-119.
38. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A., and Harlow, E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes & Dev. 11: 847-862.
39. Lam, W.-F., Glassford, J., Benrji, L., Thomas, N.S.B., Sicinski, P., and Klaus, G.G.B. 2000. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J. Biol. Chem. 275:3479-3484.
40. Lane, M.E., Sauer, K., Wallace, K., Jan, Y.N., Lehner, C.F., and Vaessin, H. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell cycle proliferation during Drosophila development. Cell 87: 1225-1235.
41. Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M.K., Han, K., Lee, J.H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27, and opposes p27-mediated G1 arrest. Nat. Med. 8:1153-1160.
42. Liu, Y.J.S.N., Howard, M., Wu, W.W., Parry, D., Lees, E., Mahony, J., Lam, E.W.-F., Glassford, J., Klaus, G.G.B., Sicinski, P., et al. 2000. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 12: 631-638.
43. Lukas, J., Pagano, M., Staskova, Z., Draetta, G., and Bartek, J. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor lines. Oncogene 9: 707-718.
44. Kip1 in G1 and S phase. Nature 413: 323-327.
45. Malumbres, M., Sotillo, R., Santamaria, D., Galan, J., Cerezo, A., Ortega, S., Dubus, P., and Barbacid, M. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504.
46. Matsushime, H., Roussel, M.F., Ashmun, R.A., and Sherr, C.J. 1991. Colony-stimulating factor-1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713.
47. PSKJ3/ CDK4) for mammalian D-type G1 cyclins. Cell 71:323-334.
48. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J., and Kato, J.-Y. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
49. Matsuura, I., Denissova, N.G., Wang, G., He, D., Long, J., and Liu, F. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430: 226-231.
50. CDC28 protein kinase activity from Saccharomyces cerevisiae. Science 259: 216-219.
51. Meyer, C.A., Jacobs, H.W., and Lehner, C.F. 2002. Cyclin D-cdk4 is not a master regulator of cell multiplication in Drosophila embryos. Curr. Biol. 12: 661-666.
52. Meyyappan, M., Wong, H., Hull, C., and Riabowol, K.T. 1998. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol. 18:3163-3172.
53. Miliani de Marval, P.L., Macias, E., Rounbehler, R., Sicinski, P., Kiyokawa, H., Johnson, D.G., Conti, C.J., and Rodriguez-Puebla, M.L. 2004. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol. Cell. Biol. 24: 7538-7547.
54. Mitra, J. and Enders, G.H. 2004. Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc2 phosphatases in human cells. Oncogene 23: 3361-3367.
55. Moons, D.S., Jirawatnotai, S., Parlow, A.F., Gibori, G., Kineman, R.D., and Kiyokawa, H. 2002. Pituitary hypoplasia and lactotroph dysfunction in mice deficient for cyclin-dependent kinase-4. Endocrinology 143:3001-3008.
56. Moore, J.D., Kirk, J.A., and Hunt, T. 2003. Unmasking the S-phase-promoting potential of cyclin B1. Science 300:987-990.
57. Morgan, D.O. 1997. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13: 261-291.
58. Murphy, M., Stinnakre, M.G., Senamaud-Beaufort, C., Winston, N.J., Sweeney, C., Kubelka, M., Carrington, M.B.C., and Sobczak-Thepot, J. 1997. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat. Genet. 15: 83-86.
59. Murray, A.W. 2004. Recycling the cell cycle: Cyclins revisited. Cell 116: 221-234.
60. Ohtsubo, M. and Roberts, J.M. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912.
61. Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M., and Pagano, M. 1995. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol. Cell. Biol. 15: 2612-2624.
62. Ortega, S., Prieto, I., Odajima, J., Martine, A., Dubus, P., Sotillo, R., Barbero, J.L., Malumbres, M., and Barbacid, M. 2003. Cyclin-dependent kinase-2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35: 25-31.
63. Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J., and Draetta, G. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121: 101-111.
64. Pagano, M., Theodoras, A.M., Tam, S.W., and Draetta, G.F. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes & Dev. 8: 1627-1639.
65. Parisi, T, Beck, A.R., Rougier, N., McNeil, T., Lucian, L., Werb, Z., and Amati, B. 2003. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22: 4794-4803.
66. Pines, J. and Hunter, T. 1990. Human cyclin A is adenovirus E1 A-associated protein p60 and behaves differently from cyclin B. Nature 346: 760-763.
67. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
68. Quelle, D.E., Ashmun, R.A., Shurtleff, S.E., Kato, J.-Y., Bar-Sagi, D., Roussel, M., and Sherr, C.J. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes & Dev. 7: 1559-1571.
69. Rane, S.G., Dubus, P., Mettus, R.V., Galbreath, E.J., Boden, G., Reddy, E.P., and Barbacid, M. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22: 44-52.
70. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
71. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
72. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGB-β. Genes & Dev. 9: 1831-1835.
73. Richardson, H.E., Wittenberg, C., Cross, F., and Reed, S.I. 1989. An essential G1 function for cyclin-like proteins in yeast. Cell 59: 1127-1133.
74. Roberts, J.M. 1999. Evolving ideas about cyclins. Cell 98: 129-132.
75. Roberts, J.M. and Sherr, C.J. 2003. Bared essentials of CDK2 and cyclin E. Nat. Genet. 35: 9-10.
76. Rodriguez-Puebla, M.L., Miliani de Marval, P.L., LaCava, M., Moons, D.S., Kiyokawa, H., and Conti, C.J. 2002. Cdk4 deficiency inhibits skin tumor development but does not affect keratinocyte proliferation. Am. J. Pathol. 161: 405-411.
77. Rowlands, T.M., Pechenkina, I.V., Hatsell, S.J., Pesteil, R.G., and Cowin, P. 2003. Dissecting the roles of β-catenin and cyclin D1 during mammary development and neoplasia. Proc. Natl. Acad. Sci. 100: 11400-11405.
78. Schneider, B.L., Yang, Q.H., and Futcher, A.B. 1996. Linkage of replication to Start by the Cdk inhibitor Sic1. Science 272: 560-562.
79. Schwenk, F., Zevnik, B., Bruning, J., Rohl, M., Willuweit, A., Rode, A., Hennek, T., Kauselmann, G., Jaenisch, R., and Kühn, R. 2003. Hybrid embryonic stem cell-derived tetraploid mice show apparently normal morphological, physiological, and neurological characteristics. Mol. Biol. Cell 23: 3982-3989.
80. SIC1 controls the G1/S transition in Saccharomyces cerevisiae. Cell 79: 233-244.
81. Serrano, M., Hannon, G.J., and Beach, D. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
82. Sheaff, R., Groudine, M., Gordon, M., Roberts, J., and Clurman, B. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes & Dev. 11: 1464-1478.
83. Sherr, CJ. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
84. Sherr, C.J. and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
85. -. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes & Dev. 13: 1501-1512.
86. Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8: 1145-1152.
87. Sicinski, P., Donaher, J.L., Parker, S.B., Li, T., Fazeli, A., Gardner, H., Haslam, S.Z., Bronson, R.T., Elledge, S.J., and Weinberg, R.J. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630.
88. Sicinski, P., Donaher, J.L., Geng, Y., Parker, S.B., Gardner, H., Park, M.Y., Robker, R.L., Richards, J.S., McGinnis, L.K., Biggers, J.D., et al. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384: 470-474.
89. Sicinska, E., Aifantis, I., Le Cam, L., Swat, W., Borowski, C., Yu, Q., Ferrando, A.A., Levin, S.D., Geng, Y., von Boehmer, H., et al. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451-461.
90. Strausfeld, U.P., Howell, M., Rempel, R., Maller, J.L., Hunt, T., and Blow, J.J. 1994. Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr. Biol. 4: 876-883.
91. Su, T.T. and O'Farrell, P.H. 1998. Chromosome association of minichromosome maintenance proteins in Drosophila endoreplication cycles. J. Cell Biol. 140: 451-460.
92. Taipale, J. and Beachy, P.A. 2001. The hedgehog and Wnt signalling pathways in cancer. Nature 411: 349-354.
93. Tetsu, O. and McCormick, F. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancel Cell 3: 233-245.
94. Tezlaff, M.T., Bai, C., Finegold, M., Wilson, J., Harper, J.W., Mahon, K.A., and Elledge, S.J. 2004. Cyclin F disruption compromises placental development and affects normal cell cycle progression. Mol. Cell. Biol. 24: 2487-2498.
95. Kip1 mice. Mol. Cell. Biol. 21: 1319-1328.
96. Trimarchi, J.M. and Lees, J.A. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3: 11-20.
97. Tsai, L.-H., Lees, E., Faha, B., Harlow, E., and Riabowol, K. 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8: 1593-1602.
98. Kip1 activity. Mol. Cell. Biol. 19: 7011-7019.
99. SIC1 imposes the requirement for Cln G1 cyclin function at Start. Proc. Natl. Acad. Sci. 93: 7772-7776.
100. Tyers, M., Tokiwa, G., and Futcher, B. 1993. Comparison of the S. cerevisiae G1 cyclins: Cln3 may be an upstream activator of Cln1, Cln2, and other cyclins. EMBO J. 12: 1955-1968.
101. van den Heuvel, S.J.L. and Harlow, E. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
102. Veiga-Fernandes, H. and Rocha, B. 2004. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat. Immunol. 5: 31-37.
103. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8: 1136-1144.
104. Kip1. EMBO J. 16: 5334-5344.
105. Wechsler-Reya, R.J. and Scott, M.P. 2001. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24: 385-428.
106. Welcker, M., Singer, J., Loeb, K.R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B.E., and Roberts, J.M. 2003. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12:381-392.
107. Won, K.-A. and Reed, S.I. 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15: 4182-4193.
108. Ye, X., Zhu, C., and Harper, J.W. 2001. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl. Acad. Sci. 98: 1682-1686.
109. Yu, Q. and Sicinski, P. 2004. Mammalian cell cycles without cyclin E-CDK2. Cell Cycle 3: 292-295.
110. Yu, Q., Geng, Y., and Sicinski, P. 2001. Specific protection against breast cancers by cyclin Dl ablation. Nature 411: 1017-1021.
111. Zou, X., Dipankar, R., Azivu, A., Christov, K., Boiko, A.D., Gudkov, A.V., and Kiyokawa, H. 2002. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes & Dev. 16:2923-2934.